This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Sirnaomics, Inc.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Dmitry Samarsky: Innovator in Oligomeric Compounds
Introduction
Dmitry Samarsky is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of oligomeric compounds that have therapeutic applications.
Latest Patents
Dmitry holds a patent for an oligomeric compound aimed at inhibiting the expression of factor XI. This patent, which is crucial for advancing medical treatments, includes products and compositions that modulate the expression of the FXI gene. The invention specifically involves nucleic acid products that can interfere with or inhibit the expression of the FXI gene, utilizing oligomeric compounds with specific nucleobase sequences.
Career Highlights
Dmitry is currently associated with Sirnaomics, Inc., where he continues to work on innovative solutions in the field of gene expression modulation. His expertise in this area has positioned him as a key player in the biotechnology sector.
Conclusion
Dmitry Samarsky's work in developing oligomeric compounds represents a significant advancement in biotechnology, with the potential to impact therapeutic strategies for various medical conditions. His contributions are paving the way for future innovations in gene expression modulation.